approved glp-1 agonists Comparing GLP-type therapies for weight loss in those without diabetes. Two glucagon-like peptide-1 receptor (GLP-1 RAs) (#semaglutide and #liraglutide) and one dual agonist (#tirzepatide) have been FDA-approved for #weightloss in adults Curious about the latest in

The next strategic priority is ensuring broader patient access

If your insurance covers brand-name Wegovy or Ozempic, youll likely pay less with insurance than you would paying cash for compounded semaglutide

doi: 10.1186/s40779-023-00485-5

And what we're finding is even though the muscle mass or the total muscle may be going down, the quality of the muscle is improving because the fat is being removed from the muscle, and function where we're looking at it is starting to improve

Publication fee of this article was waived by the publisher

Yiangou A, Mitchell JL, Nicholls M et al (2022) Obstructive sleep Apnoea in women with idiopathic intracranial hypertension: a sub-study of the idiopathic intracranial hypertension weight randomised controlled trial (IIH: WT)